O
OPKO Health, Inc. (OPK)
NMS – Real Time Price. Currency in USD
1.22
-0.00 (-0.41%)
Market open: Apr 21, 2026, 1:43 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.22
-0.00 (-0.41%)
Market open: Apr 21, 2026, 1:43 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.97 | 2.46 | 10 | |
| Quick ratio | 3.52 | 2.06 | 10 | |
| Debt to Equity | 0.31 | -0.13 | 7.0 | |
| Debt to Assets | 0.21 | 1.87 | 8.0 | |
| Interest coverage | -3.39 | 4.31 | 1.0 | |
| Weighted average score | 7.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1B | 863M | 713M | 607M | 607M |
| Gross Profit | 204M | 232M | 136M | 128M | 128M |
| Operating Income | -246M | -158M | -274M | -219M | -219M |
| Net Income | -328M | -189M | -53M | -226M | -226M |
| EBITDA | -137M | -53M | -175M | -127M | -127M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -12.93 | 30 | 5.5 |
| Next quarter | -13.06 | 63.16 | 5.5 |
| Current year | -9.18 | 7.14 | 3.0 |
| Next year | 4.24 | 10.26 | 5.5 |
| Weighted average score | 4.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -2.11 | -244.49 | -233.32 | 24.34 | 3.3 |
| Y/Y | -19.13 | -323.25 | -499.99 | 42.62 | 3.3 |
| 3y average | -15.42 | -69.89 | -53.77 | -99.15 | 1.0 |
| 5y average | -13.2 | -279.53 | -236.25 | -465.68 | 1.0 |
| Weighted average score | 2.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $369.1M barely cover the upcoming debt maturities $396.8M
Total current assets $581.9M exceed Total current liabilities $146.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (-0.1), showcasing prudent financial management
Interest coverage ratio (-3.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$28.6M limits the company's ability to reinvest or pay down debt